New light on the drug suspension East on the cash option no longer justified – of new medicines – pharmaceutical industries
Today is the "new medicine on the" three companies last trading day before the merger conversion. Subject to market rumors, "Amalgamation longer suspension," the impact of yesterday's Shanghai Medicine , The real medicine and Western medicine Gujia collective down, were down 7.53%, 4.56% and 5.43%. The reporter called Shanghai Traditional Chinese Medicine, the official said, the merger will be convertible usual procedures, implementation of the completion time will be based on the recent implementation of merger * ST ST China Eastern Airlines case. The current price above the conversion price of the three companies are also a foregone conclusion, the cash option have been meaningless.
Absorbed in the merger * ST ST China Eastern Airlines, the suspension two steps. Where, ST China Eastern shares on January 12, 2010 the cash option to declare the first consecutive day suspension, to January 14 deadline to declare that the right to request restoration of the acquisition; and * ST Airlines stock from January 12, 2010 began continuous suspension until the completion of the termination of listing procedures to terminate on January 25 listing. January 28, ST China Eastern Airlines complete convertible; February 2, add unlimited sale of shares traded.
The "new on drugs" and "East on the" suspension nodes slightly different. Shanghai Traditional Chinese Medicine, said today's announcement, on February 4 will begin to declare the cash purchase option right to request and began a continuous suspension, until the absorption of this convertible complete implementation of the merger. Medicine and Western medicine on the actual announcement said the company shares will be from February 4 to declare the cash option consecutive day suspension until the completion of termination of listing procedures, today, the last trading day for the stock.
If the implementation of the merger by absorption of suspension to complete the calculation, ST China Eastern shares from suspension to add listing, time just 15 trading days. Insiders pointed out that even the most complex Tangganggufen absorption and case, also only a month after completion of the merger of Shanghai Pharmaceutical convertible medicine and Western medicine on the actual duration of the suspension or shorter than expected.
Tangganggufen convertible absorption Handan Steel And Chengde, the three stock beginning on Dec. 16 suspension, Tangganggufen absorption from the merger of additional shares convertible traded on resumption of trading transactions. January 25, by the three companies traded shapeshift, Hebei Iron and Steel. The case of merger is considered A-share market first absorption cross-exchange listed company merger, involving the Shenzhen and Shanghai stock markets and shareholders nearly three million people, the final implementation of the completion time of 40 days.
In addition, the Shanghai Traditional Chinese Medicine, Chinese medicine and Western medicine on the actual current price above the conversion price is a foregone conclusion, the cash option have been meaningless. Yesterday, the Shanghai Pharmaceutical to close at 14.98 yuan, the real medicine to close at 23.46 yuan, to close at 13.94 yuan and Western medicine. Restructuring the convertible price, Shanghai Pharmaceutical 11.83 yuan / share, 19.07 yuan on the real medicine / Unit, Western medicine 11.36 yuan / share; three acquired companies were lower than yesterday's close of the Claim of the exercise price higher 26.63%, respectively, 23.02% and 22.71%. Insiders pointed out that objections to the shareholders the right to select the line will lead to greater losses, no one chose to exercise the purchase is expected claim.
I am Chinese Manufacturers writer, reports some information about ceiling projection alarm clock , ice chest radio.
Processing your request, Please wait....
